Neogen Corporation Increase (Decrease) in Accounts Payable and Accrued Liabilities
Neogen Corporation (NEOG) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $19.80 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-07-30
- Neogen Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-05-31 was -$700.00K.
- Neogen Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-02-28 was $15.64M, a 307.96% increase year-over-year.
- Neogen Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-11-30 was -$9.31M, a 151.59% decline year-over-year.
- Neogen Corporation increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-08-31 was $14.17M.
- Neogen Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2026 was $19.80M.
- Neogen Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$400.00K, a 102.90% decline from fiscal 2024.
- Neogen Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $13.80M, a 25.97% decline from fiscal 2023.
- Neogen Corporation increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $18.64M, a 7.89% decline from fiscal 2022.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | -$700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | $14.94M derived: sum of 2 quarters · filed 2026-07-30 | $5.63M derived: sum of 3 quarters · filed 2026-07-30 | $19.80M 10-K · filed 2026-07-30 | ||||
| 2026-02-28 | $15.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $6.33M derived: sum of 2 quarters · filed 2026-04-09 | $20.50M 10-Q · filed 2026-04-09 | $14.10M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-11-30 | -$9.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $4.86M 10-Q · filed 2026-01-08 | -$1.54M derived: sum of 3 quarters · filed 2026-07-30 | $2.29M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-08-31 | $14.17M 10-Q · filed 2025-10-09 | $7.77M derived: sum of 2 quarters · filed 2026-07-30 | $11.60M derived: sum of 3 quarters · filed 2026-07-30 | $29.65M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-05-31 | -$6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$2.57M derived: sum of 2 quarters · filed 2026-07-30 | $15.48M derived: sum of 3 quarters · filed 2026-07-30 | -$400.00K 10-K · filed 2026-07-30 | -$402.00K 10-K · filed 2025-07-30 | |||
| 2025-02-28 | $3.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-09 | $21.88M derived: sum of 2 quarters · filed 2026-04-09 | $6.00M 10-Q · filed 2026-04-09 | $5.99M 10-Q · filed 2025-04-09 | -$1.59M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2024-11-30 | $18.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-08 | $2.17M 10-Q · filed 2026-01-08 | -$5.42M derived: sum of 3 quarters · filed 2026-07-30 | -$18.98M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2024-08-31 | -$15.88M 10-Q · filed 2025-10-09 | -$23.47M derived: sum of 2 quarters · filed 2026-07-30 | -$37.03M derived: sum of 3 quarters · filed 2026-07-30 | -$7.06M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2024-05-31 | -$7.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-30 | -$21.15M derived: sum of 2 quarters · filed 2026-07-30 | $8.82M derived: sum of 3 quarters · filed 2026-07-30 | $13.80M 10-K · filed 2026-07-30 | $13.75M 10-K · filed 2024-07-30 | |||
| 2024-02-29 | -$13.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-09 | $16.41M derived: sum of 2 quarters · filed 2025-04-09 | $21.39M 10-Q · filed 2025-04-09 | $48.45M derived: sum of 4 quarters · filed 2025-07-30 | ||||
| 2023-11-30 | $29.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-15 | $34.95M 10-Q · filed 2025-01-15 | $62.01M derived: sum of 3 quarters · filed 2025-07-30 | $29.49M derived: sum of 4 quarters · filed 2025-07-30 | ||||
| 2023-08-31 | $4.98M 10-Q · filed 2024-10-10 | $32.04M derived: sum of 2 quarters · filed 2025-07-30 | -$481.00K derived: sum of 3 quarters · filed 2025-07-30 | $36.90M derived: sum of 4 quarters · filed 2025-07-30 | ||||
| 2023-05-31 | $27.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-30 | -$5.46M derived: sum of 2 quarters · filed 2025-07-30 | $31.92M derived: sum of 3 quarters · filed 2025-07-30 | $18.64M 10-K · filed 2025-07-30 | ||||
| 2023-02-28 | -$32.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-09 | $4.86M derived: sum of 2 quarters · filed 2024-04-09 | -$8.42M 10-Q · filed 2024-04-09 | $17.47M derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-11-30 | $37.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-09 | $24.10M 10-Q · filed 2024-01-09 | $30.07M 10-Q · filed 2023-01-09 | $49.99M derived: sum of 3 quarters · filed 2024-07-30 | $33.91M derived: sum of 4 quarters · filed 2024-07-30 | |||
| 2022-08-31 | -$13.28M 10-Q · filed 2023-10-10 | -$7.32M 10-Q · filed 2022-09-30 | $12.61M derived: sum of 2 quarters · filed 2024-07-30 | -$3.47M derived: sum of 3 quarters · filed 2024-07-30 | $9.34M derived: sum of 4 quarters · filed 2024-07-30 | |||
| 2022-05-31 | $25.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $9.81M derived: sum of 2 quarters · filed 2024-07-30 | $22.62M derived: sum of 3 quarters · filed 2024-07-30 | $20.24M 10-K · filed 2024-07-30 | $10.21M 10-K · filed 2022-07-27 | |||
| 2022-02-28 | -$16.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-04 | -$3.27M derived: sum of 2 quarters · filed 2023-04-04 | -$5.65M 10-Q · filed 2023-04-04 | $8.09M 10-Q · filed 2022-04-01 | $448.00K derived: sum of 4 quarters · filed 2023-08-15 | |||
| 2021-11-30 | $12.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-01-09 | $10.43M 10-Q · filed 2023-01-09 | $10.34M 10-Q · filed 2021-12-30 | $16.53M derived: sum of 3 quarters · filed 2023-08-15 | $13.79M derived: sum of 4 quarters · filed 2023-08-15 | |||
| 2021-08-31 | -$2.38M 10-Q · filed 2022-09-30 | $3.72M derived: sum of 2 quarters · filed 2023-08-15 | $977.00K derived: sum of 3 quarters · filed 2023-08-15 | |||||
| 2021-05-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-15 | $3.36M derived: sum of 2 quarters · filed 2023-08-15 | -$2.22M 10-K · filed 2023-08-15 | -$3.21M 10-K · filed 2021-07-30 | ||||
| 2021-02-28 | -$2.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-01 | -$8.32M 10-Q · filed 2022-04-01 | ||||||
| 2020-11-30 | -$5.58M 10-Q · filed 2021-12-30 | |||||||
| 2020-05-31 | $6.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | $5.43M derived: sum of 2 quarters · filed 2022-07-27 | $2.98M derived: sum of 3 quarters · filed 2022-07-27 | $6.75M 10-K · filed 2022-07-27 | ||||
| 2020-02-29 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | -$3.46M derived: sum of 2 quarters · filed 2021-03-31 | $301.00K 10-Q · filed 2021-03-31 | $6.29M derived: sum of 4 quarters · filed 2021-07-30 | ||||
| 2019-11-30 | -$2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-29 | $1.31M 10-Q · filed 2020-12-29 | $7.31M derived: sum of 3 quarters · filed 2021-07-30 | $558.00K derived: sum of 4 quarters · filed 2021-07-30 | ||||
| 2019-08-31 | $3.76M 10-Q · filed 2019-09-26 | $9.75M derived: sum of 2 quarters · filed 2021-07-30 | $3.00M derived: sum of 3 quarters · filed 2021-07-30 | $1.74M derived: sum of 4 quarters · filed 2021-07-30 | ||||
| 2019-05-31 | $5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-30 | -$755.00K derived: sum of 2 quarters · filed 2021-07-30 | -$2.02M derived: sum of 3 quarters · filed 2021-07-30 | -$1.46M 10-K · filed 2021-07-30 | ||||
| 2019-02-28 | -$6.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | -$8.02M derived: sum of 2 quarters · filed 2020-04-03 | -$7.46M 10-Q · filed 2020-04-03 | -$2.79M derived: sum of 4 quarters · filed 2020-07-30 | ||||
| 2018-11-30 | -$1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-27 | -$706.00K 10-Q · filed 2019-12-27 | $3.96M derived: sum of 3 quarters · filed 2020-07-30 | $2.30M derived: sum of 4 quarters · filed 2020-07-30 | ||||
| 2018-08-31 | $564.00K 10-Q · filed 2019-09-26 | $5.22M derived: sum of 2 quarters · filed 2020-07-30 | $3.57M derived: sum of 3 quarters · filed 2020-07-30 | $1.97M derived: sum of 4 quarters · filed 2020-07-30 | ||||
| 2018-05-31 | $4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-30 | $3.00M derived: sum of 2 quarters · filed 2020-07-30 | $1.40M derived: sum of 3 quarters · filed 2020-07-30 | $4.38M 10-K · filed 2020-07-30 | ||||
| 2018-02-28 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-29 | -$3.26M derived: sum of 2 quarters · filed 2019-03-29 | -$280.00K 10-Q · filed 2019-03-29 | -$7.55M derived: sum of 4 quarters · filed 2019-07-30 | ||||
| 2017-11-30 | -$1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-28 | $1.38M 10-Q · filed 2018-12-28 | -$5.89M derived: sum of 3 quarters · filed 2019-07-30 | -$7.15M derived: sum of 4 quarters · filed 2019-07-30 | ||||
| 2017-08-31 | $2.98M 10-Q · filed 2018-10-05 | -$4.29M derived: sum of 2 quarters · filed 2019-07-30 | -$5.55M derived: sum of 3 quarters · filed 2019-07-30 | -$2.97M derived: sum of 4 quarters · filed 2019-07-30 | ||||
| 2017-05-31 | -$7.27M derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-30 | -$8.53M derived: sum of 2 quarters · filed 2019-07-30 | -$5.95M derived: sum of 3 quarters · filed 2019-07-30 | -$1.69M 10-K · filed 2019-07-30 | ||||
| 2017-02-28 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-29 | $1.32M derived: sum of 2 quarters · filed 2018-03-29 | $5.58M 10-Q · filed 2018-03-29 | |||||
| 2016-11-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $6.84M 10-Q · filed 2018-01-05 | ||||||
| 2016-08-31 | $4.26M 10-Q · filed 2017-09-29 | |||||||
| 2016-02-29 | -$2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-31 | $2.09M derived: sum of 2 quarters · filed 2017-03-31 | $2.10M 10-Q · filed 2017-03-31 | |||||
| 2015-11-30 | $4.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-29 | $4.78M 10-Q · filed 2016-12-29 | ||||||
| 2015-08-31 | $16.00K 10-Q · filed 2016-09-30 | |||||||
| 2015-02-28 | -$1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-31 | -$1.95M derived: sum of 2 quarters · filed 2016-03-31 | -$2.06M 10-Q · filed 2016-03-31 | $2.06M 10-Q · filed 2015-04-01 | ||||
| 2014-11-30 | -$470.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-08 | -$576.00K 10-Q · filed 2016-01-08 | ||||||
| 2014-08-31 | -$106.00K 10-Q · filed 2015-09-30 | |||||||
| 2014-02-28 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-01 | -$836.00K derived: sum of 2 quarters · filed 2015-04-01 | $3.11M 10-Q · filed 2015-04-01 | |||||
| 2013-11-30 | -$2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-30 | $1.87M 10-Q · filed 2014-12-30 | ||||||
| 2013-08-31 | $3.95M 10-Q · filed 2014-09-30 | |||||||
| 2013-02-28 | $3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-04-04 | $3.63M derived: sum of 2 quarters · filed 2014-04-04 | $2.98M 10-Q · filed 2014-04-04 | |||||
| 2012-11-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-09 | -$608.00K 10-Q · filed 2014-01-09 | ||||||
| 2012-08-31 | -$644.00K 10-Q · filed 2013-09-30 | |||||||
| 2012-02-29 | -$256.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | -$27.00K derived: sum of 2 quarters · filed 2012-03-30 | $430.00K 10-Q · filed 2012-03-30 | |||||
| 2011-11-30 | $229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | $686.00K 10-Q · filed 2011-12-30 | ||||||
| 2011-08-31 | $457.00K 10-Q · filed 2011-09-30 | |||||||
| 2011-02-28 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-30 | $328.00K derived: sum of 2 quarters · filed 2012-03-30 | $2.52M 10-Q · filed 2012-03-30 | |||||
| 2010-11-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-30 | $3.83M 10-Q · filed 2011-12-30 | ||||||
| 2010-08-31 | $2.20M 10-Q · filed 2011-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |